INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,897,563 | +20.7% | 4,225,000 | 0.0% | 0.18% | +25.9% |
| Q2 2023 | $3,227,900 | -5.8% | 4,225,000 | 0.0% | 0.14% | +32.4% |
| Q1 2023 | $3,426,352 | -9.4% | 4,225,000 | 0.0% | 0.10% | +8.2% |
| Q4 2022 | $3,783,910 | -23.2% | 4,225,000 | -15.5% | 0.10% | -10.2% |
| Q3 2022 | $4,925,000 | +74.3% | 5,000,000 | 0.0% | 0.11% | +68.8% |
| Q2 2022 | $2,825,000 | -38.2% | 5,000,000 | 0.0% | 0.06% | -46.2% |
| Q1 2022 | $4,571,000 | -19.7% | 5,000,000 | 0.0% | 0.12% | -18.5% |
| Q4 2021 | $5,694,000 | -17.0% | 5,000,000 | 0.0% | 0.15% | -25.9% |
| Q3 2021 | $6,861,000 | -21.3% | 5,000,000 | 0.0% | 0.20% | -19.6% |
| Q2 2021 | $8,713,000 | -0.2% | 5,000,000 | 0.0% | 0.24% | -22.0% |
| Q1 2021 | $8,732,000 | +6.7% | 5,000,000 | 0.0% | 0.31% | +9.4% |
| Q4 2020 | $8,184,000 | -23.7% | 5,000,000 | 0.0% | 0.29% | -26.2% |
| Q3 2020 | $10,721,000 | -57.0% | 5,000,000 | 0.0% | 0.39% | -64.9% |
| Q2 2020 | $24,916,000 | +232.9% | 5,000,000 | 0.0% | 1.11% | +343.2% |
| Q1 2020 | $7,484,000 | – | 5,000,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AQR Arbitrage LLC | 4,225,000 | $3,897,563 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,690,000 | $5,247,864 | 0.06% |
| D. E. Shaw & Co., Inc. | 6,500,000 | $6,049,225 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |